Summary. The presence of the epidermal growth factor receptor (EGFR) 
Introduction
Growth factors are likely to take part in the regulation of spermatogenesis, working possibly in a paracrine or autocrine fashion within the testis (reviewed by Bellve & Zheng, 1989; Skinner, 1991) . Epidermal growth factor (EGF) has elicited much interest regarding its potential effects on spermatogenesis. For example, sialoadenectomy of adult male mice led to the elimination of circulating plasma EGF (measured by radioimmunoassay), without a concomitant decrease in gonadotrophin and androgen concentrations and caused a marked decrease in male fertility (Tsutsumi et al., 1986) . Replacement therapy with EGF reversed the deleterious effects of sialoadenectomy on male fertility. Recent studies have been able to corroborate, in part, these findings (Russell et ai, 1990; Seethalakshimi et al., 1991) . Further, in experimentally induced diabetic mice that exhibit EGF deficiency that leads to the pathogenesis of oligozoospermia, daily administration of EG F significantly increased the number of spermatozoa (Noguchi er a/., 1990 ). In addition, functional studies of both Leydig cells (Ascoli, 1981; Welsh & Hsueh, 1982 ; Bernierer al., *Reprint requests.
1986; Verhoeven & Cailleau, 1986) and Sertoli cells (Mallea et ai, 1986; Smith et ai, 1987; Morris et al., 1988) in vitro have elucidated potential mechanisms of EGF action on spermatogenesis. Taken together, these studies suggest that EGF could act directly on the testis to bring about its effects on spermatogenesis.
Epidermal growth factor exerts its biological effects through a specific 170 kDa transmembrane protein, the EGF receptor (reviewed in Ullrich et ai, 1984; Schlessinger, 1986; Gill et al., 1987; Carpenter, 1987) . The (Bartlett et ai, 1990 ) and a recent study reported changes in the concentration of EGF receptor mRNA in testes of monkeys approaching puberty (Keeping, 1991 
Antibody
The antibody used in this study, RK2, was raised against a carboxy-terminus sequence (DVVDADEYLIPQ) that corresponds to residues 984-996 of the intracellular domain of the human EGF receptor (Kris et al., 1985) and was a generous gift of F. Bellot (Rhone-Poulenc Rorer Central Research, Horsham, PA). This antibody was used for both immunoblotting and immunostaining methods. The validity of RK.2 as an antibody probe for the EGF receptor of a broad range of species, including mice, rats, humans and chickens, was documented recently (Bellot et al., 1990 
Membrane preparations
Membranes from liver, testis and epididymis were prepared for adrenal cortex by the method of Culty (1984) and adapted for the above tissues by Suarez-Quian & Niklinski ( 1990) . The tissues were first minced as finely as possible with scissors and washed and homogenized in homogenizing buffer (10 mmol Tris-HCl 1"', 2 mmol EGTA l"1, 0-25 mol sucrose 1" ', pH 7-4) using a Polytron homogenizer (Brinkmann Industries, Westbury, NY) for 30 s. The homogenate was centrifuged at 800 # for 10 min, at 10 000 # for 15 min and at 100 000 g for 40 min, collecting the supernatant each time for the subsequent centrifugation. The resulting pellet was suspended in a buffer containing 50 mmol Tris-HCl 1~' , 5 mmol EGTA ', mmol PMSF1 " ' (pH 7-4). Membranes from A431 cells were also prepared in this manner. Protein concentration in these preparations was determined using the Bio-Rad Protein Determination Kits (Bradford, 1976) .
Western blot
Solubilized membrane proteins (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) pg) were separated in 7-5% acrylamide gels by polyacrylamide gel electrophoresis (PAGE) (Laemmli, 1970) Richmond, CA). After the proteins were transferred onto a nitrocellulose membrane using a Bio-Rad Mini Trans Blot Electrophoretic Transfer Cell, immunoblotting was carried out as described by Burnett (1981) using nonfat dry milk (Johnson et al., 1984) in the following order: incubation of the nitrocellulose membrane with 5% nonfat milk in phosphate-buffered saline (PBS) containing 002% sodium azide overnight; incubation with primary antibody (RK2 1:500) for 1 h at room temperature; treatment with 2-5% milk in PBS plus 01% Triton X-100; wash with 2-5% milk in PBS; incubation with secondary antibody (horseradish peroxidase conjugated donkey anti-rabbit antibody diluted 1:300 with 2-5% milk in PBS) for 1 h; repeat washings as before; finally incubation with substrate chromogen mixture (hydrogen peroxide-aminoethyl carbazol). Membrane preparations from A431, the cell line used as the EGF receptor antigen source, were used as positive controls to determine the specific band recognized by the RK2 antibody. In addition we used membrane preparations from livers of male primates, as a positive control tissue source, since the liver isa prominent source of EGF receptors (O'Keefe et ai, 1974) with male livers having twice the numbers of EGF receptors as the female liver (Kashimata et ai, 1988 ).
Immunocytochemistry
The biotin-streptavidin-peroxidase immunocytochemical staining, a direct and sensitive method of antigen detection, was used to demonstrate the distribution of EGF receptors in testis, epididymis and vas deferens. In this immunostaining technique a positive reaction is characterized by a reddish brown reaction product. The primate liver was used as a positive control for the immunostaining procedure, since previous studies in rodents (Dunn et ah, 1986) have demonstrated prominent immunostaining of EGF receptor in this tissue in a characteristic pattern. Frozen sections, 5-7 pm thick, were cut from liver, testis, epididymis and vas deferens using a Reichert-Jung 2000E cryostat. The sections were fixed in 3-7% formaldehyde for 10 min, permeabilized with 0-1% Triton X-100 for 45 s and washed with PBS several times. The immunostaining was then carried out using Histostain-SP Kits (Zymed Laboratories, Burlingame, CA) as described by Suarez-Quian & Niklinski (1990) . Briefly, endogenous peroxidase activity was blocked by a 45 s treatment with periodic acid solution (Zymed) and endogenous avidin and biotin were blocked using the commercially available avidin and biotin blocking solutions (Zymed) per manufacturer's instructions, followed by blocking nonspecific antibody binding with 10% nonimmune goat serum, incubated with either pre-immune serum or RK2 antibody (diluted 1:400), and immunostained using biotinylated goat anti-rabbit antibody, streptavidinperoxidase and substrate-chromogen mixture. The sections were then counterstained with haematoxylin and examined with a Zeiss, Planapo 63 phase 3, 1-4 N.A. objective using an 80A blue filter and images recorded on Kodacolor 100 ASA film. Photographs were processed by a professional photographic laboratory (CPI, Bethesda, MD).
Results

Immunoblotting
The expression of EGF receptors by A431 cells is represented by the prominent band which corresponds to approximately 170 kDa, the molecular mass of EGF receptor, as discerned from the molecular weight standards (Fig. 1) 
Immunostaining
In primates, the EGF receptors were distributed on the basolateral membranes of hepatocytes lining the liver sinusoids (Fig. 2a) . This reaction product was conspicuously absent from the pre¬ immune treated liver section (Fig. 2b) . The cells of the haemopoietic system were devoid of EGF receptors and so were the erythrocytes in liver sections (Fig. 2b) . The pre-immune treated testis sections were devoid of any positive staining for EGF receptors (Fig. 2c) .
The testis sections showed the distribution of EGF receptors in Sertoli cells, peritubular cells ( Fig. 2d and e) (Fig. 3a) . However, the smooth muscle layers of the duct were devoid of EGF receptor staining (Fig. 3b and c) . The pattern of immunostaining in vas deferens was quite similar to that observed in the epididymis; immunostaining was prominent on the basolateral and luminal borders of the epithelial cells lining the ductus deferens (3d and e). As in the epididymis, none of the smooth muscle layers in vas deferens showed any positive immunostaining.
The distribution of the EGF receptors in the epididymis of pubertal monkeys was also determined. Using this technique a similar distribution of EGF receptors was observed in the epididymis, both basolateral and luminal immunostaining was prominent (Fig. 4) (Carpenter, 1987) (Skinner et al., 1989) . Since epidermal growth factor was first isolated (Cohen, 1962) , its role as a potent mitogen for various cells (reviewed in Carpenter & Cohen, 1979; Gospodarowicz, 1981) , as well as for certain endocrine cell lines (reviewed in Fisher & Lakshmanan, 1990) (Werner et al., 1988 (Ikeda et al., 1984; Kudlow & Kobrin, 1984) and prolactin secretion (Johnson et al., 1980) . Similarly, the EGF receptor immunostaining described in this study is consistent with previous functional studies in rat (Rich et ai, 1983) , stimulation of lactate production (Mallea et al., 1986) , and production of inhibin (Morris et al., 1988) appear to be partly under EGF control. The effects of EGF on gonadal steroid production in males include inhibition of aromatization by Sertoli cells in vitro (Mallea et al., 1986) , diminution of human chorionic gonadotrophin (hCG)-binding sites on Leydig cells (Ascoli, 1981) and inhibition of hCG-stimulated testosterone production by Leydig cells in vitro (Welsh & Hsueh, 1982) , although a later report described a stimulatory effect of EGF in the presence of gonadotrophins (Verhoeven & Cailleau, 1986) which has been shown to be mediated by increasing the availability of cholesterol substrate (Sordoillet et ai, 1991 (Carpenter, 1987 (Maratos-Flier et al., 1987) . In contrast, although our interpretation is not definitive, the immunofluorescence data demonstrating vesicular structures akin to coated vesicles and endosomes along the apical borders of the epididymal principal cells favour the suggestion of a luminal EGF. In this regard EGF has been detected in human seminal fluid and in tissue homogenates from testis and epididymis (Elson et ai, 1984) ; an EGF-like molecule was identified in culture media from mouse and human Sertoli cells (Holmes et al., 1986; Buch et al., 1988) ; and transforming growth factor alpha (TGF-) has been immunolocalized in adult rat testis (Teerds et al., 1990) . Similarly, non-human primates should Fig. 4 . Epidermal growth factor receptor (EGFR) localization in caput epididymis by immuno¬ fluorescence. Frozen sections of epididymis were prepared as described in legend to Fig. 3 and immunostained for EGFR, except that localization was performed using immunofluorescence. Corresponding phase images of fluorescence profiles (a) and (c) are shown in (b) and (d), respectively. Note that basolateral (triangles) and apical (arrows) EGFR immunostaining is also observed using this technique. In addition, the vesicular nature of the apical immunostaining is readily apparent. Magnification (a), (b) 180; (c), (d) 400. be investigated to determine whether they also produce an EGF or EGF-like growth factor that may travel downstream to the epididymides where it may be internalized by receptor-mediated endocytosis. Regardless of the path travelled by EGF in the epididymis and vas deferens, the presence of EGF receptors in these tissues suggest further studies on the potential role of EGF in the functions of epididymis and vas deferens.
Our studies indicate the cell sites of action of EGF in primate testis and epididymis; the potential role of EGF in production and maturation of spermatozoa in primates warrants new venues for investigations in fertility and infertility control in man.
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